Claudin-1 as a promoter of EMT in hepatocellular carcinoma

Oncogene

Volumn 32, Issue 41, 2013, Pages 4871-4872

  Stebbing, J ^a   Filipovic A ^a   Giamas, G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

c Abl; Claudin 1; ERK; hepatocellular cancer; invasion; Ras

Indexed keywords

ABELSON KINASE; BETA CATENIN; CLAUDIN 1; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; RAF PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

CLAUDIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LIVER; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION;

EID: 84885082894     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.591     Document Type: Article

References (11)

1. Roxburgh P, Evans TR. Systemic therapy of hepatocellular carcinoma: are we making progress? Adv Ther 2008; 25: 1089-1104.
2. Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene 2013; 32: 1743-1868.
3. Turksen K, Troy TC. Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 2011; 1816: 73-79.
4. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J oncol 2010; 2010: 541957.
5. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005; 65: 9603-9606. (Pubitemid 41541431)
6. Myal Y, Leygue E, Blanchard AA. Claudin 1 in breast tumorigenesis: revelation of a possible novel 'claudin high' subset of breast cancers. J Biomed Biotechnol 2010; 2010: 956897.
7. Tabaries S, Dupuy F, Dong Z, Monast A, Annis MG, Spicer J et al. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes. Mol Cell Biol 2012; 32: 2979-2991.
8. Yoon CH, Kim MJ, Park MJ, Park IC, Hwang SG, An S et al. Claudin-1 acts through c-Abl-protein kinase Cdelta (PKCdelta) signaling and has a causal role in the acquisition of invasive capacity in human liver cells. J Biol Chem 2010; 285: 226-233.
9. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005; 115: 1765-1776. (Pubitemid 40979715)
10. Cervello M, McCubrey JA, Cusimano A, Lampiasi N, Azzolina A, Montalto G. Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Onco-target 2012; 3: 236-260.
11. Suzuki H, Kondoh M, Takahashi A, Yagi K. Proof of concept for claudin-targeted drug development. Ann NY Acad Sci 2012; 1258: 65-70.